DiabetesontheNet - Live & Virtual Events for Diabetes Clinicians

Diabetes
on the net
Live

A leading online events and interactive learning platform for healthcare professionals managing diabetes.
Sign up now to engage with the experts.

TAKE A LOOK AT OUR

upcoming
online events

fORward thinking in type 2 diabetes: Optimising adult care to improve outcomes
Tue 21 Sep 2021 | Tue 19 Oct 2021
+ additional dates

View & register

This promotional webcast series has been developed, organised and funded by Novo Nordisk for UK healthcare professionals only. Novo Nordisk product information will be discussed. Prescribing information and adverse events reporting will be available at this webcast series.

14th Scottish Conference of the Primary Care Diabetes Society
Tue, 26 Oct 2021

View & register

SoliMix – Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Suliqua®▼ as a favourable alternative to premixed insulin
Tue, 2 Nov 2021

View and register

This promotional webinar was initiated and fully funded by Sanofi. The content has been reviewed and approved by the sponsoring company and the speakers prior to broadcast. Editorial support for this webinar was provided by OmniaMed Communications.
Prescribing information for Suliqua® (insulin glargine 100 units/mL and lixisenatide) can accessed by clicking here.

17th National Conference of the Primary Care Diabetes Society
Thu, 18 Nov 2021 • Fri, 19 Nov 2021

View & register

14th All-Ireland Conference of the Primary Care Diabetes Society
Sat, 27 Nov 2021

View & register

11th Northern Ireland Conference of the Primary Care Diabetes Society
Thu, 16 Sept 2021

View & register

Trulicity® (dulaglutide): Significant efficacy, simply achieved, and higher dose data
Fri, 10 Sept 2021 at 13:00

View and register

This promotional webinar has been developed and funded by Lilly. Lilly products will be discussed at this online event. Prescribing information for Trulicity® (dulaglutide) can be accessed by Clicking here. OmniaMed Communications has provided editorial, marketing and logistical support. Lilly is a registered trademark of Eli Lilly and Company © 2021 Eli Lilly and Company. All rights reserved.
PP-DG-GB-0910 | August 2021

COVID-19 and type 2 diabetes in adults: Assessing ongoing learnings and examining where our focus should be moving forward
Wed, 03 Nov 2021

View & register

This promotional webinar has been developed, organised and funded by Boehringer Ingelheim. The content has been reviewed and approved by the sponsoring company and the speakers prior to the webinar. The speakers have received an honorarium to take part in this promotional webinar. Editorial support for this webinar has been provided by OmniaMed Communications.
Click here for prescribing and adverse event reporting details for:
Great Britain
Northern Ireland
Ireland
PC-GB-105382 | September 2021

Changing Paradigms - Emerging teatment options for adolescents with obesity
Tue, 9 Nov 2021

View & register

This promotional resource is organised and funded by Novo Nordisk. The information presented is intended for UK-based healthcare professionals.

Changing Paradigms – a focus on obesity management in Scotland
Wed, 3 Nov & Thu, 4 Nov 2021

View & register

This promotional resource is organised and funded by Novo Nordisk. The information presented is intended for Scotland-based healthcare professionals.

Changing Paradigms - Emerging teatment options for adolescents with obesity
Tue, 9 Nov 2021

View & register

This promotional resource is organised and funded by Novo Nordisk. The information presented is intended for UK-based healthcare professionals.

SoliMix – Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Suliqua as a favourable alternative to premixed insulin
Tue, 2 Nov 2021

View and register

This promotional webinar was initiated and fully funded by Sanofi. The content has been reviewed and approved by the sponsoring company and the speakers prior to broadcast. Editorial support for this webinar was provided by OmniaMed Communications. Prescribing information for Suliqua® (insulin glargine 100 units/mL and lixisenatide) can accessed by clicking here.

TAKE A LOOK AT OUR

On-Demand
videos

PCDS Question Time 2021
On-demand webinars and resources to enable reflection and discussion

View the videos & resources

This virtual broadcast series has been funded by Boehringer Ingelheim. Boehringer Ingelheim has had no editorial input into, or influence over, the content of the webinar. PCDS is solely responsible for the content of the webinar and the selection of speakers.

21st Annual abracadabra diabetes nursing conference
On-Demand videos from the annual conference

View the videos

This on-demand content has been developed, organised and funded by Lilly in conjunction with the Abracadabra Programme Planning Committee. Lilly Products will be discussed, and prescribing information will be available.

12th Welsh Conference of the Primary Care Diabetes Society
On-demand webinars from the annual PCDS conference

View the videos

Delivery of Diabetes Care in the Primary Care Network: The changing shape of clinical practice

View Videos

Changing Paradigms - A focus on obesity management in the UK

View Videos

This promotional resource is organised and funded by Novo Nordisk. The information presented is intended for UK-based healthcare professionals.

Time in range - is this the new gold standard?
Exploring the role of technology and modern insulins for improving glycaemic control in diabetes

View the video

This promotional resource is organised and funded by Novo Nordisk and Abbott. Marketing and organisational support has been provided by OmniaMed Communications. The information presented is intended for UK-based healthcare professionals. Adverse event reporting information and Prescribing Information will be available.

Diabetes perspectives: An introduction to Flash Glucose Monitoring
On-demand webinar

View the video

How to Optimise Remote Consultations in Diabetes
Speakers: Pam Brown & Jane Diggle

View the video

This broadcast was funded by Novo Nordisk. Novo Nordisk has had no editorial input into, or control over, the content of the webinar. PCDS is responsible for the content of the webinar and selection of speakers.

Virtual PCDS Smart Update in diabetes
Interpreting latest evidence and guidance to drive improved patient care

View videos & resources’

This independent programme has been funded by AstraZeneca. AstraZeneca has had no editorial input into, or control over the content. PCDS is responsible for the content of all materials and selection of speakers pertaining to this